📰 Given Ocugen News
Given Ocugen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Ocugen. Real-time updates on events, politics, business and more.
November 22, 2023
Pluri (NASDAQ:PLUR – Get Free Report) and Ocugen (NASDAQ:OCGN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Profitability This table compares Pluri and Ocugen’s net margins, […]
July 18, 2023
Ocugen (NASDAQ:OCGN – Get Free Report) and Kiromic BioPharma (NASDAQ:KRBP – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings. Valuation & Earnings This table compares Ocugen and […]
July 15, 2023
Ocugen (NASDAQ:OCGN – Get Free Report) and Kiromic BioPharma (NASDAQ:KRBP – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Institutional & Insider Ownership 27.5% of Ocugen shares […]
July 15, 2023
Kiromic BioPharma (NASDAQ:KRBP – Get Free Report) and Ocugen (NASDAQ:OCGN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Institutional & Insider Ownership 2.1% of Kiromic BioPharma […]
June 6, 2023
Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation. Risk & Volatility Bio-Techne has a beta of 1.26, meaning that its […]
May 30, 2023
Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Risk & Volatility Bio-Techne has a beta of 1.25, suggesting that its […]